<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "journalpublishing3.dtd">
<article xml:lang="en" article-type="retraction" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<?release-delay 0|0?>
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">OL</journal-id>
<journal-title-group>
<journal-title>Oncology Letters</journal-title>
</journal-title-group>
<issn pub-type="ppub">1792-1074</issn>
<issn pub-type="epub">1792-1082</issn>
<publisher>
<publisher-name>D.A. Spandidos</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3892/ol.2024.14232</article-id>
<article-id pub-id-type="publisher-id">OL-27-3-14232</article-id>
<article-categories>
<subj-group>
<subject>Retraction</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>[Retracted] MicroRNA‑30a suppresses the proliferation, migration and invasion of human renal cell carcinoma cells by directly targeting ADAM9</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author"><name><surname>Jiang</surname><given-names>Lining</given-names></name>
</contrib>
<contrib contrib-type="author"><name><surname>Liu</surname><given-names>Yabin</given-names></name>
</contrib>
<contrib contrib-type="author"><name><surname>Ma</surname><given-names>Can</given-names></name>
</contrib>
<contrib contrib-type="author"><name><surname>Li</surname><given-names>Binghui</given-names></name>
</contrib>
</contrib-group>
<pub-date pub-type="collection">
<month>03</month>
<year>2024</year></pub-date>
<pub-date pub-type="epub">
<day>15</day>
<month>01</month>
<year>2024</year></pub-date>
<volume>27</volume>
<issue>3</issue>
<elocation-id>100</elocation-id>
<permissions>
<copyright-statement>Copyright: &#x00A9; Jiang et al.</copyright-statement>
<copyright-year>2024</copyright-year>
<license license-type="open-access">
<license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, reproduction and adaptation in any medium and for any purpose provided that it is properly attributed. For attribution, the original author(s), title, publication source (PeerJ) and either DOI or URL of the article must be cited.</license-p></license>
</permissions>
</article-meta>
</front>
<body>
<p>Oncol Lett 16: <related-article xmlns:xlink="http://www.w3.org/1999/xlink" related-article-type="retracted-article" vol="16" page="3038" id="RA1" xlink:href="10.3892/ol.2018.8999" ext-link-type="doi">3038&#x2013;3044</related-article>, 2018; DOI: 10.3892/ol.2018.8999</p>
<p>Subsequently to the publication of this paper, the authors contacted the Editorial Office to explain that, during the preparation of the data in Figs. 2C and 4D, they inadvertently included two sets of different data to represent the same experiments, and that, in fact, only the set of data panels featured on the left for each of the figure parts was intended to have been included in these figures.</p>
<p>The authors requested the publication of a corrigendum; however, after a subsequent investigation of the matter in the Office, as many as three pairs of overlapping data panels were identified comparing the data panels that were intended to have been included in the figures with those that were not. After careful consideration, the Editor of <italic>Oncology Letters</italic> has decided that the paper should be retracted from the journal on account of a lack of overall confidence in the originally presented data. Upon contacting the authors, they accepted the Editor&#x0027;s decision to retract the article. The Editor regrets any inconvenience caused to the readership.</p>
</body>
</article>
